Stepwise imaging evaluation | No. of exams | ||||||||
First step | Second step | Third step | CE-US | CT | MRI (§) | FNB (*) | Aggregate cost (Euros) | Total cost per patient (Euros) | |
Study criteria | |||||||||
CE-US | CT | MRI | † | 55 | 45 | 34 | 33 | 28667 | 535a |
CE-US | MRI | CT | † | 55 | 40 | 43 | 33 | 30215 | 545b |
CT | CE-US | MRI | † | 39 | 54 | 34 | 33 | 28909 | 544c |
CT | MRI | CE-US | † | 34 | 54 | 37 | 33 | 29346 | 553d |
MRI | CT | CE-US | † | 34 | 40 | 52 | 33 | 30970 | 580e |
MRI | CE-US | CT | † | 38 | 36 | 52 | 33 | 30607 | 577f |
AASLD criteria | |||||||||
CE-US and CT | MRI | ‡ | 55 | 54 | 11 | 43 | 26440 | 479g | |
CE-US and MRI | CT | ‡ | 55 | 16 | 52 | 43 | 30922 | 558h | |
CT and MRI | CE-US | ‡ | 11 | 54 | 52 | 43 | 33898 | 623i |
Statistically significative differences: a vs i=0.03; b vs i=0.048; c vs i=0.04; e vs g=0.003; f vs g=0.004; g vs h=0.0002; g vs i=0.0001; h vs i=0.0007.
↵* Not performed in two patients due to contraindications.
↵† FNB performed in nodules with undefined radiological diagnosis. 33 vs 43 FNB procedures: p=0.031.
↵‡ HCC diagnosis by at least one single imaging technique.
↵§ HCC diagnosis by at least two imaging techniques performed at the same time point.
CE-US, contrast-enhanced ultrasound; FNB, fine needle biopsy.